GlaxoSmithKline PLC, the world's second largest drug maker by revenue, reported Thursday that its fourth-quarter profit soared by 66 percent, boosted by strong sales of swine flu vaccine and flu medicine. In the three months ending Dec. 31, Glaxo turned a net profit of 1 ...

BASEL, Switzerland (Reuters) - Roche Holding AG missed full-year profit forecasts due to disappointing sales of key cancer drugs and gave a Lackluster outlook for 2010, pointing up the wider challenges facing global drugmakers. Roche has focused on developing promising new drugs rather than cutting costs as a way to combat looming patent losses, but still faces some of the same ...

Andrew Witty, who took over as GlaxoSmithKline PLC's chief executive in May 2008, has been remaking the company from a pure pharmaceutical business to a diverse healthcare conglomerate, a strategy most rivals now are pursuing. The London-based maker of asthma treatment Advair and heartburn drug ...